Financials
Financial year 2025
Associatie Nefrologie AZ Sint–Lucas Assebroek from Brugge, company number BE0693956707, closed financial year 2025 with a result of € 0 after tax. For that financial year Associatie Nefrologie AZ Sint–Lucas Assebroek recorded a gross margin of € 5,227 and equity of € 10,106. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 10,106
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 0
Profit after tax over the fiscal year.
€ 14,891
▼ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 0.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 6,796
▲ 112% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,566
▲ 222% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 6,292 | € 3,815 | € 3,753 | € 5,227 | ▲ 39% |
| Equity | € 10,106 | € 10,106 | € 10,106 | € 10,106 | |
| Total debts | € 1,147,266 | € 1,223,625 | € 1,248,306 | € 1,098,447 | ▼ 12% |
| Cash | € 18,021 | € 21,752 | € 20,395 | € 14,891 | ▼ 27% |
| Bank debt | € 2,330 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 1,157,372 | € 1,233,731 | € 1,258,412 | € 1,108,553 | ▼ 12% |
Key figures of Associatie Nefrologie AZ Sint–Lucas Assebroek, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Associatie Nefrologie AZ Sint–Lucas Assebroek?
What happened at Associatie Nefrologie AZ Sint–Lucas Assebroek in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 0. Source: NBB ↗
- Paronef BV became a director. NBB
- New establishment in Brugge. KBO
- Horizon BV became a director. NBB
- Dr. Laute Margo, Nefrologie BV became a director. NBB
- Dr. Sylvie Vermeire Nefrologie BV became a director. NBB
- Dr. Grijalba - Dr. Reyns BV became a director. NBB
- Drs. Huygens-Vandermarliere BV became a director. NBB
In short
From € 0 profit in 2022 to € 0 profit in 2025.
Paid € 8,224 in corporate taxes since 2022.
A new publication or filing at Associatie Nefrologie AZ Sint–Lucas Assebroek? We notify you, reason included.
Follow Associatie Nefrologie AZ Sint–Lucas AssebroekDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Dr. Grijalba - Dr. Reyns, DR.SYLVIE VERMEIRE NEFROLOGIE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Associatie Nefrologie AZ Sint–Lucas AssebroekBehind Associatie Nefrologie AZ Sint–Lucas Assebroek are Horizon BV, Dr. Laute Margo, Nefrologie BV, Dr. Sylvie Vermeire Nefrologie BV, Dr. Grijalba - Dr. Reyns BV, Drs. Huygens-Vandermarliere BV and Paronef BV. The shares are held by Dr. Grijalba - Dr. Reyns (14.3%) and DR.SYLVIE VERMEIRE NEFROLOGIE (12.5%).
Directors
According to the 2025 annual accounts
Director · represented by Dr. Luyckx Christine
since 2018
Dr. Laute Margo, Nefrologie BV
Director · represented by Dr. Margo Laute
since 2018
Dr. Sylvie Vermeire Nefrologie BV
Director · represented by Dr. Sylvie Vermeire
since 2018
Chairman of the board · represented by Dr. Liza-Maria Reyns
since 2018
Drs. Huygens-Vandermarliere BV
Director · represented by Dr. Annemie Vandermarliere
since 2018
Director · represented by Dr. Pannecoeck Roos
since 2025
Director · represented by Dr. Bert Vandewiele
since 2018
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Sint-Lucaslaan 29
8310 Brugge
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0693.956.707
- VAT number
- BE 0693.956.707
- Registered office
- Sint-Lucaslaan 29, 8310 Brugge
- Names & denominations
- Associatie Nefrologie AZ Sint–Lucas Assebroek
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 April 2018
- Peppol
- Active · Active since 28 Jul 2026
- Activities · NACE
Activiteiten van medisch specialisten